CHM.CN Stock Surges 900% in April 2026 Trading Session

Waverunner Capital Inc. (CHM.CN) delivered a stunning 900% surge on the Canadian CNQ exchange today, with shares climbing to C$0.05 from a previous close of C$0.005. This dramatic move marks one of the most extreme single-day rallies we’ve tracked in the venture capital sector. The North Vancouver-based firm, which rebranded from Chemistree Technology Inc. in June 2024, specializes in early-stage investments across biotech, renewable energy, and plant-based wellness. Today’s explosive action reflects the high-risk, high-reward nature of micro-cap venture plays. We’ll examine what’s driving this volatility and what investors need to know about CHM.CN stock.

Understanding the 900% Price Explosion

CHM.CN stock’s 900% jump represents an extraordinary move for any security, let alone a venture capital firm trading at penny stock levels. The stock climbed from C$0.005 to C$0.05 in a single session, though trading volume data remains unavailable, making it difficult to assess the breadth of this move.

This type of extreme volatility is common in micro-cap stocks where thin liquidity amplifies price swings. Waverunner Capital’s market cap sits at approximately C$37.2 million, making it highly susceptible to large percentage moves on modest trading activity. The company’s year-to-date performance shows a 400% gain over five days, suggesting recent momentum has been building before today’s explosion.

Company Profile and Investment Strategy

Waverunner Capital Inc. operates as a venture capital firm focused on early-stage and seed-stage investments across multiple sectors. The company targets equity investments between C$500,000 and C$1 million, with enterprise values ranging from C$2 million to C$5 million.

The firm maintains a diversified portfolio spanning renewable energy (wind and solar), plant-based wellness, consumer-targeted biotechnology, and resources. CEO Karl Eric Kottmeier leads the organization from its North Vancouver headquarters. Waverunner makes investments through both its own balance sheet and personal capital, giving it flexibility in deployment. Track CHM.CN on Meyka for real-time updates on this venture capital player’s movements.

Financial Metrics and Valuation Concerns

CHM.CN stock trades at deeply negative fundamentals that warrant caution. The company reports a negative EPS of -C$0.01 and a negative PE ratio of -5.0, indicating ongoing losses. Net income per share stands at -C$0.0595, while operating cash flow per share is -C$0.0045.

The current ratio of 0.097 signals severe liquidity stress, well below the healthy 1.5 threshold. Working capital is negative at -C$520,504, and tangible asset value is negative at -C$705,780. These metrics suggest the company is burning through resources. Meyka AI rates CHM.CN with a grade of B based on sector comparison, financial metrics, and analyst consensus. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.

Market Sentiment and Trading Activity

Today’s 900% surge reflects extreme market sentiment swings typical of penny stocks. Average daily volume sits at just 28,908 shares, meaning even modest buying pressure can trigger outsized percentage moves.

The stock’s year-high of C$0.10 and year-low of C$0.05 show the security has traded in a narrow range despite today’s explosion. The 50-day moving average of C$0.0424 and 200-day average of C$0.0481 suggest the stock has been consolidating near current levels. Without official volume data for today’s session, we cannot confirm whether this move reflects genuine institutional interest or speculative retail activity in a thinly traded security.

Final Thoughts

CHM.CN’s 900% surge to C$0.05 reflects extreme volatility in a micro-cap venture firm facing serious financial distress. Negative earnings, poor liquidity, and negative working capital signal underlying problems despite the dramatic price action. While Waverunner Capital’s diversified portfolio in biotech, renewable energy, and wellness offers potential, current fundamentals require caution. Thin trading volume and penny-stock status guarantee continued volatility. Investors must conduct thorough due diligence and recognize the high-risk nature of venture capital investments at these levels.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.